About Wellpartner
Wellpartner is a company based in Tualatin (United States) founded in 2000. Wellpartner has raised $37.6 million across 3 funding rounds from investors including 3i Group, Burrill and Company and Montlake Capital. The company has 89 employees as of December 31, 2022. Wellpartner has completed 2 acquisitions, including 340B SMART and Solutionsrx340b. Wellpartner operates in a competitive market with competitors including Pharmaceutical Strategies Group, Equiscript, PharMedQuest, doc&i and 340BDirect, among others.
- Headquarter Tualatin, United States
- Employees 89 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.6 M (USD)
in 3 rounds
-
Latest Funding Round
$16.1 M (USD), Series D
Aug 01, 2008
-
Investors
3i Group
& 6 more
-
Employee Count
89
as on Dec 31, 2022
-
Investments & Acquisitions
340B SMART
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Wellpartner
Unlock access to complete
Funding Insights of Wellpartner
Wellpartner has successfully raised a total of $37.6M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $16.1 million completed in August 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wellpartner
Wellpartner has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include 3i Group, Burrill and Company and Montlake Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on mid-market businesses
|
Locked | Locked | Locked | |
|
Investment support is offered for businesses in the Pacific Northwest.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Wellpartner
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wellpartner
Wellpartner has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include 340B SMART and Solutionsrx340b.
Investment portfolio details for Wellpartner
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Split billing solutions for 340B-eligible medications are provided automatically.
|
Locked | Locked | 2013 | Locked | |
|
340B compliance solutions for pharmacies are provided by Solutionsrx340b.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Wellpartner
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wellpartner
Detailed financials for Wellpartner
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wellpartner Comparisons
Peer comparison for Wellpartner
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wellpartner
Wellpartner operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaceutical Strategies Group, Equiscript, PharMedQuest, doc&i and 340BDirect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacy intelligence platform and clinical consulting services are provided.
|
|
| Locked | Locked | Locked |
Provider of pharmacy management services
|
|
| Locked | Locked | Locked |
Medical benefit management for specialty healthcare is developed.
|
|
| Locked | Locked | Locked |
Cloud-based prescription transparency software
|
|
| Locked | Locked | Locked |
Delivers tools for managing 340B programs in pharmacies.
|
Detailed competitors of Wellpartner
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wellpartner
Complete news archive for Wellpartner
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wellpartner
Wellpartner was founded in 2000 and raised its 1st funding round 5 years after it was founded.
Wellpartner is headquartered in Tualatin, United States. It is registered at Tualatin, Oregon, United States.
Wellpartner is a funded company, having raised a total of $37.6M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Wellpartner is 89.
Wellpartner was founded in 2000 and is based in Tualatin, United States, operating in the healthcare sector with a focus on 340B compliance. Services such as AccessConvergence are offered for program management, including claims administration, specialty pharmacy dispensing, and health plan coordination. Pharmaceuticals are dispensed through a nationally licensed, URAC-, ACHC-, and VIPPS-accredited specialty pharmacy to patients of hospitals and clinics. Existing pharmacy solutions are complemented to support health outcomes.
Wellpartner's top competitors include Pharmaceutical Strategies Group, PharMedQuest and Elevate340B.
Wellpartner has made 2 acquisitions, including 340B SMART, and Solutionsrx340b.
Wellpartner has 7 investors. Key investors include 3i Group, Burrill and Company, Montlake Capital, Integra Ventures, and Mediphase Venture Partners.